Sorrento Therapeutics Inc (SRNE): In Benzinga interview Dr.Ji emphasized S...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	57
Posts	5700
Boards Moderated	0
Alias Born	12/13/2004

dia76ca

Re: CharlesNet post# 13367

Saturday, 03/26/2022 10:01:59 PM

Saturday, March 26, 2022 10:01:59 PM

In Benzinga interview Dr.Ji emphasized SEMDEXA aiming for Breakthrough Designation followed by marketing approval within 6 months. Also Mpro oral antiviral enter clinic in April with signs it does not have drug/drug interactions of the Pfizer drug. COVISHIELD covers all covid variants. COVIMARK approval packages before US FDA and Health Canada. AND application for COVIMARK APPROVAL IN CHINA...gigantic market!

"The refusal of the real is the number one dogma of our time" Rene Girard

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM